摘要

<正>Hepatocellular carcinoma (HCC) is a common malignant tumor with a high mortality rate, especially in Asian countries [1]. Currently, lipiodol-based transcatheter arterial embolization (TAE) has been extensively applied for patients with intermediate or advanced stages, which significantly prolongs survival [2]. However, the clinical therapeutic outcome of TAE synergistic